TMDX - TransMedics Group, Inc.

108.91
-4.220   -3.875%

Share volume: 809,843
Last Updated: 04-21-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.04%

PREVIOUS CLOSE
CHG
CHG%
$113.13
-4.22
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
37%
Profitability 25%
Dept financing 21%
Liquidity 65%
Performance 45%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-6.01%
1 Month
-2.83%
3 Months
-21.13%
6 Months
-8.89%
1 Year
19.41%
2 Year
25.89%
Key data
Stock price
$108.91
P/E Ratio 
21.85
DAY RANGE
$108.55 - $113.80
EPS 
$5.60
52 WEEK RANGE
$88.50 - $156.00
52 WEEK CHANGE
$18.06
MARKET CAP 
4.157 B
YIELD 
N/A
SHARES OUTSTANDING 
34.302 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
07-30-2025
BETA 
1.06
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$758,739
AVERAGE 30 VOLUME 
$894,310
Company detail
CEO: Waleed H. Hassanein
Region: US
Website: transmedics.com
Employees: 210
IPO year: 2019
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

TransMedics Group, Inc. engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system. OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation.

Recent news